This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Index funds combine broad market exposure with low expenses, often improving risk-adjusted returns for long-term investors. This guide explains the appeal.
22,458 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Oil markets face geopolitical headwinds and growing demand, keeping prices above the $90 threshold. This article iden...
Ukraine expands its drone-defense footprint in the Middle East, signaling a broader role for Kyiv as global markets w...
Oil and currency markets tremble as new Iran-related tensions top the global agenda. Asia, with its export-led growth...
A pullback in AbbVie has some investors asking if the stock looks like a bargain. This guide explains why that view m...
A New Mexico verdict against Meta and a California ruling involving Meta and YouTube mark a turning point in lawsuits...
When a mining stock pops, traders look beyond a single catalyst. This article breaks down why coeur mining stock popp...
TON climbs from about $1.30 to $2.50 in three days as Telegram signals a major governance shift, slashing fees and ta...
Take a practical tour of arcutis (arqt) 2026 earnings, from revenue mix and margins to pipeline progress and risk fac...
A cross-border pilot connects Ripple’s XRPL to interbank rails, enabling near real-time settlement of tokenized Treas...
A new Goldman Sachs Asset Management survey shows that even high earners face a squeeze between income and expenses, ...
A new pediatric guidance warns that american schools have been quietly cutting recess in pursuit of test scores, risk...